GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Intermune, Inc. (ITMN) [hlAlert]

Rating:
Outperform
ITMN
up 92.74 %

Intermune, Inc. (ITMN) rated Outperform by Wells Fargo

Posted on: Wednesday,  Mar 10, 2010  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Intermune, Inc. (NASDAQ: ITMN) on 03/10/2010, when the stock price was $38.34. Since
then, Intermune, Inc. has gained 92.75% as of 09/26/2014's recent price of $73.90.
If you would have followed this Wells Fargo's recommendation on ITMN, you would have gained 92.74% of your investment in 1661 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2010 8:25 AM Buy
None
38.34
as of 12/31/2010
1 Week down  -5.29 %
1 Month up  179.37 %
3 Months up  157.63 %
1 YTD down  -8.47 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy